And other biotech news brought to you by The Readout
Want to stay on top of the science and politics driving biotech today?
Sign up
to get our biotech newsletter in your inbox.
The FDA’s surprise refusal to even review Moderna’s mRNA flu vaccine is sending a chill through biotech: Companies are openly wondering whether the regulatory goalposts are shifting under the Trump administration.
Programming note: This newsletter is taking a holiday on Monday but will be back in your inbox on Tuesday.
Continue to STAT+ to read the full story…
— Source: STAT News (https://www.statnews.com/2026/02/13/biotech-news-pediatricians-confront-hhs-vaccine-showdown/)
